Effect of Mosapride Citrate on Gastric Emptying in Interferon-Induced Gastroparesis

Background and Objectives Gastroparesis, a gastrointestinal autonomic neuropathy, is a common adverse reaction in chronic hepatitis C (CHC) patients receiving interferon therapy. Current therapeutic options are limited. We evaluated the efficacy of mosapride for IFN-induced gastroparesis.